Literature DB >> 10079015

Plant alkaloid tetrandrine downregulates protein kinase C-dependent signaling pathway in T cells.

L J Ho1, D M Chang, T C Lee, M L Chang, J H Lai.   

Abstract

Tetrandrine, a purified traditional Chinese medicinal herb that acts as an immunosuppressant and a Ca2+ channel blocker, has been clinically used to treat patients with arthritis, silicosis and hypertension. Since T cells play a critical role as autoreactive and pathogenic population in autoimmune diseases, in this study, we examined the immunosuppressive effect of tetrandrine on human peripheral blood T cells. We showed that tetrandrine inhibited phorbol 12-myristate 13-acetate (PMA) + ionomycin-induced T cell proliferation, interleukin-2 secretion and the expression of the T cell activation antigen, CD71. Further investigation of the molecular mechanism demonstrated that tetrandrine inhibited the expression of the protein kinase C-dependent interleukin-2 receptor alpha chain and CD69 but not the expression of the Ca2+-dependent CD40 ligand and CD69. Interestingly, when tetrandrine and cyclosporin A were added together, significant synergism in the suppression of T cell activation was observed. Moreover, of the several tetrandrine analogues studied, hernandezine was the most potent inhibitor of protein kinase C signaling events. These results also suggest that the protein kinase C-inhibitory capacity of tetrandrine and its analogues may not be associated with their function as Ca2+ channel blockers. Lastly, we showed that, within therapeutic concentrations, tetrandrine and its analogues could induce cellular apoptosis, which is defective in autoimmune diseases. In conclusion, our findings provide novel information about the molecular mechanism of the immunosuppressive effect of tetrandrine and its analogues in human peripheral blood T cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10079015     DOI: 10.1016/s0014-2999(98)00941-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

Review 1.  Pharmacology of tetrandrine and its therapeutic use in digestive diseases.

Authors:  D G Li; Z R Wang; H M Lu
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

2.  Tetrandrine suppresses LPS-induced astrocyte activation via modulating IKKs-IkappaBalpha-NF-kappaB signaling pathway.

Authors:  Shu-Ting Lin; Ying Wang; Yang Xue; De-Chun Feng; Yan Xu; Ling-Yun Xu
Journal:  Mol Cell Biochem       Date:  2008-05-23       Impact factor: 3.396

3.  Tetrandrine protects mouse retinal ganglion cells from ischemic injury.

Authors:  Weiyi Li; Chen Yang; Jing Lu; Ping Huang; Colin J Barnstable; Chun Zhang; Samuel S Zhang
Journal:  Drug Des Devel Ther       Date:  2014-03-21       Impact factor: 4.162

4.  Interaction Effects between Doxorubicin and Hernandezine on the Pharmacokinetics by Liquid Chromatography Coupled with Mass Spectrometry.

Authors:  Yang Song; Yuan Zhang; Wei-Peng Zhang; Bao-Zhen Zhang; Ke-Fei Wang; Xue-Song Feng
Journal:  Molecules       Date:  2019-10-08       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.